Supplementary
: IL-17 enhances the proliferation/self-renewal of GSCs. Primary glioma cells generated from malignant glioma specimens or U87-MG glioma cell line were seeded in 96-well plates (2 × 10 4 cells/well) and cultured in the presence of IL-17. After 4 days, cell viability was evaluated by WST-1 assay. Cell viability was expressed as percent of control (cells cultured with medium alone) and are shown in (A and F). The data represents mean ± S.D. of three independent experiments with similar results. Proliferation or self-renewal of GSCs was also evaluated by CFSE dissemination assay. CFSE-labeled primary glioma cells (B-E) and U87-MG cells (G-J) were plated in a 48-well round bottom plate in the presence of IL-17 (1 × 10 5 cells/well). The cultures were incubated for 4 days at 37°C and then analyzed by flow cytometry. The number of cell divisions as a measure of cell proliferation was evaluated by using the Proliferation Wizard Module of the ModFit LT Macintosh software. Results are expressed as relative frequency (percentage) of cells undergoing cell divisions. In Figures S3C, S3E , S3H and S3J, the dividing cells are designated by cell division numbers 1, 2, 3, 4, and 5, where number 1 represents parent cell population (blue histogram). In primary glioma culture, there were 38% dividing and 61.7% parent GSCs in IL-17 treatment group ( Figure S3E ) compared to 34% dividing GSCs and 64% parent in medium control ( Figure S3C ). Similarly, in U87-MG culture, there were 85% dividing GSCs and 12% parent in IL-17 group ( Figure S3I ) compared to only 78% dividing GSCs and 20.2% parent in the control ( Figure S3H ). The data is representative of two independent experiments with similar results.
